Clinical Trial Update: PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compares adjuvant modified FOLFIRINOX with Capecitabine or Gemcitabine in patients who have undergone resection for ampullary adenoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Adenocarcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)
• Modified FOLFIRINOX (modified FOLFIRINOX)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Ampullary Adenocarcinoma | Phase 3 | Status: RECRUITING